Product Wiki · Recalls · U.S. FDA — Device Enforcement

Recall Z-0421-2024 — ICM LNQ22 LINQ II, Model LNQ22; Insertable Cardiac Monitor

U.S. FDA — Device Enforcement · United States · 2023-11-03 · Class II

AI-assisted, human-edited — this page is drafted with AI from public-source data, then reviewed before publication. How we use AI →
Agency
U.S. FDA — Device Enforcement
Recall identifier
Z-0421-2024
Date of alert
2023-11-03
Country / jurisdiction
United States
Risk level
Class II
Risk type
recall
Brand
Medtronic Inc.
Product category
device
Product type
Devices
Barcode (EAN/GTIN)
00763000060374
Reported risk: It may create the potential for amplified noise and/or overall signal reduction of the ICM, which may interfere with intended recordings of heart rhythms. This noise pattern is different from occasional noise due to device position/migration, patient activity, or external electromagnetic interference.
Primary source: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.